Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Magellan Midstream Partners, L.P. (MMP): Hedge Funds Aren’t Crazy About It, Insider Sentiment Unchanged

Page 1 of 2

In the 21st century investor’s toolkit, there are many metrics investors can use to track publicly traded companies. A duo of the most useful are hedge fund and insider trading movement. At Insider Monkey, our research analyses have shown that, historically, those who follow the best picks of the elite investment managers can trounce the broader indices by a healthy margin (see just how much).

Equally as necessary, positive insider trading sentiment is another way to look at the financial markets. Just as you’d expect, there are a number of reasons for an insider to cut shares of his or her company, but just one, very simple reason why they would behave bullishly. Several academic studies have demonstrated the market-beating potential of this strategy if “monkeys” know where to look (learn more here).

Furthermore, it’s important to analyze the recent info for Magellan Midstream Partners, L.P. (NYSE:MMP).

How have hedgies been trading Magellan Midstream Partners, L.P. (NYSE:MMP)?

At the end of the second quarter, a total of 8 of the hedge funds we track were long in this stock, a change of -27% from the previous quarter. With the smart money’s sentiment swirling, there exists a few notable hedge fund managers who were upping their stakes significantly.

Magellan Midstream Partners, L.P. (NYSE:MMP)Out of the hedge funds we follow, Osterweis Capital Management, managed by John Osterweis, holds the largest position in Magellan Midstream Partners, L.P. (NYSE:MMP). Osterweis Capital Management has a $89 million position in the stock, comprising 3.3% of its 13F portfolio. On Osterweis Capital Management’s heels is Jim Simons of Renaissance Technologies, with a $27 million position; the fund has 0.1% of its 13F portfolio invested in the stock. Other peers that hold long positions include Matthew Hulsizer’s PEAK6 Capital Management, Richard Driehaus’s Driehaus Capital and Russell Lucas’s Lucas Capital Management.

Since Magellan Midstream Partners, L.P. (NYSE:MMP) has experienced bearish sentiment from the top-tier hedge fund industry, it’s safe to say that there was a specific group of fund managers that decided to sell off their positions entirely at the end of the second quarter. It’s worth mentioning that Chuck Royce’s Royce & Associates sold off the biggest stake of the 450+ funds we monitor, valued at an estimated $39.4 million in stock. Michael Messner’s fund, Seminole Capital (Investment Mgmt), also dropped its stock, about $4.7 million worth. These transactions are interesting, as aggregate hedge fund interest fell by 3 funds at the end of the second quarter.

How have insiders been trading Magellan Midstream Partners, L.P. (NYSE:MMP)?

Legal insider trading, particularly when it’s bullish, is most useful when the primary stock in question has seen transactions within the past half-year. Over the last half-year time frame, Magellan Midstream Partners, L.P. (NYSE:MMP) has experienced zero unique insiders buying, and zero insider sales (see the details of insider trades here).

We’ll go over the relationship between both of these indicators in other stocks similar to Magellan Midstream Partners, L.P. (NYSE:MMP). These stocks are Pembina Pipeline Corp (NYSE:PBA), Energy Transfer Partners LP (NYSE:ETP), El Paso Pipeline Partners, L.P. (NYSE:EPB), Kinder Morgan Management, LLC (NYSE:KMR), and Oneok Partners LP (NYSE:OKS). This group of stocks belong to the oil & gas pipelines industry and their market caps match MMP’s market cap.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!